Oculis Holding AG

NASDAQ:OCS

Biotechnology

Healthcare
$7.44 -2.43%

-$0.28 today

Market cap
$459.29M
Beta
0.13
P/E (TTM)
-5.5
EPS (TTM)
-$1.61
52W Low $10.52High $34.48

Volume 0.15M

Average 0.65M

Cash Flow

Check whether earnings turn into cash.

Operating Cash Flow

-$62.22M

FY 2025 · Annual

Investing Cash Flow

-$59.38M

FY 2025 · Annual

Financing Cash Flow

$178.60M

FY 2025 · Annual

+230.6% YoY

Cash Flow Statement

CHF
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Net Income(18.52M)(38.64M)(88.7M)(85.94M)(94.51M)
Depreciation & Amortization235K299K287K406K546K
Deferred Income Tax00000
Stock-Based Compensation328K804K3.61M9.78M16.04M
Change in Working Capital(791K)6M(12.99M)14.16M(70.67K)
Accounts Receivables233K(152K)36K247K1.9M
Inventory00000
Accounts Payables30K3.04M3.73M(1.71M)(1.86M)
Other Working Capital(1.05M)3.11M(16.76M)15.62M(106.97K)
Other Non-Cash Items4.93M6.47M43.95M14.09M15.77M
Operating Cash Flow(13.83M)(25.07M)(53.85M)(47.5M)(62.22M)
Capital Expenditures(28K)(3.55M)(48K)(230K)(287.47K)
Acquisitions (Net)00000
Purchases of Investments00(54.16M)(17.33M)(58.05M)
Sales of Investments00000
Other Investing Activities0(3.48M)000
Investing Cash Flow(28K)(3.55M)(54.21M)(17.56M)(59.38M)
Debt Repayment(98K)(159K)(158K)(274K)(373K)
Common Stock Issued00135.62M53.54M178.95M
Common Stock Repurchased00000
Dividends Paid00000
Other Financing Activities(804K)(157K)(5.79M)763K16.77K
Financing Cash Flow55.19M1.71M129.67M54.03M178.6M
Effect of Forex Changes(16K)418K(3.08M)407K174.39K
Net Change in Cash41.33M(26.49M)18.54M(10.62M)57.17M
Free Cash Flow(13.85M)(28.62M)(53.89M)(47.73M)(62.51M)

Free Cash Flow

Net Income to FCF bridge

FY2025

= Net Income-$94.5M
+ D&A$546.0K
+ Stock-Based Comp$16.0M
+ Deferred Tax$0
- Working Capital-$70.7K
+ Other Non-Cash$15.8M
= Operating Cash Flow-$62.2M
- Capex-$287.5K
= Free Cash Flow-$62.5M

Analysis

FY2025 free cash flow is -$62.5M. FCF conversion is 66.1% of net income. Operating cash flow was -$62.2M, with capex of -$287.5K. The largest bridge item is Stock-Based Comp at $16.0M.

Recent Filings

Recent regulatory filings

FilingDescriptionDate
6-K6-K filingNov 3, 2026
424B5424B5 filingNov 3, 2026
6-K6-K filingSep 30, 2026
6-K6-K filingAug 10, 2026
S-8S-8 filingAug 6, 2026

Does OCS generate free cash flow?

Oculis Holding AG (OCS) generated -$62.51M of free cash flow in fiscal 2025.

How much operating cash flow does OCS produce?

Operating cash flow was -$62.22M, before capital expenditures of $287,470.00.